Osteoporosis

5 trials MedDRA PT
5 Registered trials
0 Recruiting
4 Unique sponsors
1 Unique IMPs
4 Commercial trials
Drug classes (ATC)
— ATC code not specified 4
M Musculoskeletal (ATC M) 1
Mechanism of action (INN-stem analysis)
Monoclonal antibody 1 substance
Phase III: 1 Phase II: 1 Phase I (Other): 1 Other: 2

Filter these 5 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 5 trials

Phase III

1 trial

Phase II

1 trial
  • Odense University Hospital Academic
    IMP not specified
    2022-502076-23-00 1 country 2023 n=120
    Ended

Phase I (Other)

1 trial
  • Faes Farma S.A. Commercial
    IMP not specified
    2024-519666-43-00 1 country 2025 n=18
    Ended

Other

2 trials
  • Oractive Swiss AG Commercial
    IMP not specified
    2024-513615-26-00 1 country 2024 n=24
    Ended
  • Xentria Inc. Commercial
    IMP not specified
    2023-509749-11-00 2 countries 2024 n=225
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Xentria Inc. Commercial 2 Other, Phase III 0
Oractive Swiss AG Commercial 1 Other 0
Faes Farma S.A. Commercial 1 Phase I (Other) 0
Odense University Hospital Academic 1 Phase II 0
New trials by year
2023
1
2024
2
2025
1
← All indication landscapes